Applied Therapeutics, Inc.

Symbol: APLT on Nasdaq
Entity: Company
Industry: Pharmaceutical Preparations (Office Of Life Sciences)
Business address: 545 Fifth Avenue, Suite 1400, 10017 New York, NY
Phone: 212-220-9226
State of incorporation: DE
Fiscal year end: December 31
Category: Non-accelerated filer
Smaller reporting company
All SEC filings: View on sec.gov

Get insider transactions for this issuer

Applied Therapeutics, Inc. has filed 470 SEC EDGAR filings since 2/8/2017

Latest Filings

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
SCHEDULE 13G/A	Open Document	Open Filing		May 15, 2025		005-91017
SCHEDULE 13G/A	Open Document	Open Filing		May 15, 2025		005-91017
10-Q	Open Document \| Data	Open Filing	10-Q	May 14, 2025	Mar 31, 2025	001-38898
8-K	Open Document \| Data	Open Filing	8-K	May 13, 2025	May 13, 2025	001-38898
SCHEDULE 13G/A	Open Document	Open Filing		May 7, 2025		005-91017
SCHEDULE 13G	Open Document	Open Filing		May 7, 2025		005-91017
SCHEDULE 13G	Open Document	Open Filing		Apr 30, 2025		005-91017
ARS	Open Document	Open Filing	ARS	Apr 28, 2025	Dec 31, 2024	001-38898
DEFA14A	Open Document	Open Filing	DEFA14A	Apr 28, 2025		001-38898
DEF 14A	Open Document \| Data	Open Filing	DEF 14A	Apr 28, 2025	Jun 9, 2025	001-38898
S-8	Open Document	Open Filing	S-8	Apr 24, 2025		333-286731
PRE 14A	Open Document \| Data	Open Filing	PRE 14A	Apr 18, 2025	Jun 9, 2025	001-38898
10-K	Open Document \| Data	Open Filing	10-K	Apr 15, 2025	Dec 31, 2024	001-38898
8-K	Open Document \| Data	Open Filing	8-K	Apr 15, 2025	Apr 14, 2025	001-38898
NT 10-K	Open Document	Open Filing	NT 10-K	Mar 31, 2025	Dec 31, 2024	001-38898
4	Open Document	Open Filing	4	Mar 26, 2025	Mar 24, 2025
4	Open Document	Open Filing	4	Mar 26, 2025	Mar 24, 2025
4	Open Document	Open Filing	4	Mar 26, 2025	Mar 24, 2025
4	Open Document	Open Filing	4	Mar 6, 2025	Mar 4, 2025
4	Open Document	Open Filing	4	Mar 6, 2025	Mar 4, 2025
4	Open Document	Open Filing	4	Mar 6, 2025	Mar 4, 2025
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-91017
SCHEDULE 13G	Open Document	Open Filing		Feb 14, 2025		005-91017
SCHEDULE 13G	Open Document	Open Filing		Feb 14, 2025		005-91017
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-91017
SCHEDULE 13G	Open Document	Open Filing		Feb 14, 2025		005-91017
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-91017
8-K	Open Document \| Data	Open Filing	8-K	Feb 10, 2025	Feb 7, 2025	001-38898
4	Open Document	Open Filing	4	Feb 7, 2025	Feb 6, 2025
4	Open Document	Open Filing	4	Feb 7, 2025	Feb 6, 2025
4	Open Document	Open Filing	4	Feb 7, 2025	Feb 6, 2025
SCHEDULE 13G/A	Open Document	Open Filing		Feb 7, 2025		005-91017
SCHEDULE 13G/A	Open Document	Open Filing		Feb 5, 2025		005-91017
SCHEDULE 13G/A	Open Document	Open Filing		Feb 3, 2025		005-91017
SCHEDULE 13G/A	Open Document	Open Filing		Jan 27, 2025		005-91017
4	Open Document	Open Filing	4	Dec 20, 2024	Dec 19, 2024
4	Open Document	Open Filing	4	Dec 20, 2024	Dec 19, 2024
3	Open Document	Open Filing	3	Dec 20, 2024	Dec 19, 2024
8-K	Open Document \| Data	Open Filing	8-K	Dec 20, 2024	Dec 19, 2024	001-38898
8-K	Open Document \| Data	Open Filing	8-K	Dec 10, 2024	Dec 6, 2024	001-38898
SCHEDULE 13G/A	Open Document	Open Filing		Dec 6, 2024		005-91017
8-K	Open Document \| Data	Open Filing	8-K	Dec 2, 2024	Dec 2, 2024	001-38898
8-K	Open Document \| Data	Open Filing	8-K	Nov 27, 2024	Nov 27, 2024	001-38898
SC 13G/A	Open Document	Open Filing	SC 13G/A	Nov 14, 2024		005-91017
SC 13G/A	Open Document	Open Filing	SC 13G/A	Nov 14, 2024		005-91017
SC 13G/A	Open Document	Open Filing		Nov 14, 2024		005-91017
SC 13G/A	Open Document	Open Filing	JANUS AMENDMENT	Nov 14, 2024		005-91017
SC 13G/A	Open Document	Open Filing	APPLIED THERAPEUTICS, INC.	Nov 14, 2024		005-91017
SC 13G/A	Open Document	Open Filing	SC 13G/A	Nov 13, 2024		005-91017
SC 13G	Open Document	Open Filing		Nov 8, 2024		005-91017

Previous1 2 3 4 5…10Next

Showing 1 to 50 of 470 entries